Breaking News
Start for Free 0
🧐 ProPicks AI October update is out now! See which stocks made the list Pick Stocks with AI
Close

Beyond Air Inc (XAIR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Beyond Air's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.384 +0.050    +14.98%
- Closed. Currency in USD ( Disclaimer )
After Hours
0.389
+0.005
+1.302%
- Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,615,665
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.320 - 0.389
Beyond Air 0.384 +0.050 +14.98%

Beyond Air Company Profile

 
Explore the Beyond Air company profile for core details about Beyond Air, assess Beyond Air company details, including a description of the company, key contact information, and insights into the top executives. Discover the company's operations and leadership to better understand its role in the industry.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

107

Equity Type

ORD

Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through two segments, Beyond Air and Beyond Cancer. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. In addition, the company develops ultra-high concentration NO in Phase 1 clinical trial to treat solid tumors. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.

Contact Information

Address 900 Stewart Avenue Suite 301
Garden City, 11530
United States
Phone 516 665 8200
Fax -

Top Executives

Name Age Since Title
Steven Adam Lisi 51 2017 CEO & Chairman of the Board
William P. Forbes 62 2018 Independent Director
Robert F. Carey 65 2019 Independent Director
David Greenberg 64 - Member of Scientific Advisory Board
Andrew R. Colin - 2013 Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board
Hannah Blau - - Member of Scientific Advisory Board
Yoori Lee 50 2018 Independent Director
Erick J. Lucera 56 2017 Independent Director
Yossef Av-Gay 62 2011 Member of Scientific Advisory Board
Richard Malley - - Member of Scientific Advisory Board
Ron Bentsur 58 2017 Independent Director
Stacey Martiniano - - Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

XAIR Comments

Write your thoughts about Beyond Air Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email